Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Liver Diseases 2019

About Conference


Conference Series LLC LTD cordially welcomes you to attend the “International Congress on Liver Diseases and Hepatology” which scheduled on Sep 27-28, 2019 in Hong Kong. The main objective of the conference is to bring together leading academicians, scientists, researchers, graduate students and business delegates from the field of medical (Gastroenterologists, Hepatologists, Nephrologists, Pathologists, Virologists, Oncology) environmental specialist & pharmaceutical specialist and others from all over the world. Liver Diseases 2019 is a two days conference organized by Organizing Committee Members where it starts with a keynote session followed by oral presentation and poster presentations and final ends with the certificate distribution.

Hepatology is the study of Liver, gall bladder, biliary tree and pancreas and its disorders. This is the best chance for all the doctors as well as scientific researchers and students to find out the new techniques in Hepatology and find out the different ways of treatments to be given to the patients affected with Hepatitis. So, don’t miss the opportunity and be a part of it as the new era begins.

With members from around the world focused on learning about Liver Diseases and Hepatology. This is your best opportunity to reach the largest assemblage of participants from the Hepatology community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new developments and research, and receive name recognition at this event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Liver Diseases and Hepatology, treatment and surgery involved are hallmarks of this conference.

Targeted Audience:

Gastroenterologists

Hepatologists

Pathologists

Gynecologists

Radiologists

Oncologists

Research scholars

Doctors and General Physicians

Biotechnology and Bioinformatics students

Deans and Professors of Medicine & Hepatology departments

Professors & Students from cancer research centers

R&D department in pharmacy

Clinical Development Physicians, Researchers & Scientists

Public Health Professional

Medical Equipment Manufacturers

Hospitals and Health Services

Medical & Health care Organizations & Associations

Pancreas and Liver research institutes

Nurse and nursing education institutions

Medical Colleges

Business Professionals

Distributors/Sales Representatives

Pharmaceutical Companies

Cancer research universities in Asia-pacific regions

Sessions/Tracks

Track 1: Liver Health

It's not something you probably think much about, but your liver is a key player in your body's digestive system. Everything you eat or drink, including medicine, passes through it. You need to treat it right, so it can stay healthy and do its job. Eat a healthy diet and get regular exercise. Your liver will thank you. You'll keep your weight under control, which helps prevent nonalcoholic fatty liver disease (NAFLD), a condition that leads to cirrhosis. Watch out for certain medicines. Some cholesterol drugs can occasionally have a side effect that causes liver problems. Alcoholic beverages can create many health problems. They can damage or destroy liver cells and scar your liver.

Track 2: Liver Function

The liver is the body’s largest internal organ that sits on the right-hand side of the belly. It is an essential organ that has many functions in the body, including making proteins and blood clotting factors, manufacturing triglycerides and cholesterol, glycogen synthesis and bile production. The liver filters the blood coming from the digestive tract and detoxifies the chemicals and metabolizes the vitamins, proteins, fats, carbohydrates and drugs. The liver secretes the bile that ends up back in the intestine.

Track 3: Liver and Biliary

The liver is the largest gland in the body and conducts a myriad of vital metabolic and excretory functions. In addition, by virtue of its circulatory relationship to the absorptive surface of the gastrointestinal tract, the liver is the initial site where ingested nutrients, and other substances entering via the gastrointestinal tract, such as drugs and bacterial metabolites, are processed by the body. Thus, the liver is a gate-keeper that can process useful substances while detoxifying orally absorbed substances that are potentially harmful, such as toxic xenobiotics.

Track 4: Liver Diseases

The liver is responsible for many critical functions within the body. It helps your body digest food, store energy, and remove poisons. If it becomes diseased or injured, the loss of those functions can cause significant damage to the body. There are over 100 different forms of liver disease that affect men, women and children. These diseases include cirrhosis, alcohol abuse, hepatitis A, B, C, D, and E, Epstein Barr virus (infectious mononucleosis), non-alcoholic fatty liver disease and iron overload (hemochromatosis). The main symptoms of liver imbalance include weakness and fatigue, weight loss, nausea, vomiting, and yellow discolouration of the skin (jaundice).

Track 5: Liver Diseases Diagnosis

Screening for Liver diseases has been advocated with the intention of intervening to halt its progression. Abnormal liver tests are those that measure synthesis of proteins made by the liver (albumin, clotting factors) or the liver's capacity to metabolize drugs. The impact of the diagnosis of hepatitis C virus on quality of life is worse in patients aware of their viral status compared with individuals unaware of their viral status.

Track 6: Liver Cirrhosis

Cirrhosis is a late stage of scarring (fibrosis) of the liver caused by many forms of liver diseases and conditions, such as hepatitis and chronic alcoholism. Cirrhosis occurs in response to damage to your liver. Each time your liver is injured, it tries to repair itself. In the process, scar tissue forms. As cirrhosis progresses, more and more scar tissue forms, making it difficult for the liver to function. Cirrhosis occurs in response to damage to your liver. Each time your liver is injured, it tries to repair itself. In the process, scar tissue forms. As cirrhosis progresses, more and more scar tissue forms, making it difficult for the liver to function which include Fluid accumulation in your abdomen (ascites), Confusion, drowsiness and slurred speech (hepatic encephalopathy), Testicular atrophy in men, Breast enlargement in men. Cirrhosis can also cause portal hypertension, Enlargement of the spleen (splenomegaly).

Track 7: Liver Diseases and Nutritional Management

Nourishment has for quite some time been perceived as a prognostic and helpful determinant in patients with the perpetual liver malady. Exact evaluations of health status are not easily gotten in patients with cirrhosis fundamentally because of the inconsistencies in fluid homeostasis and compartmentalization, protein assimilation and bone exhibiting and remineralization that depict this condition. This makes it difficult to perceive those in threat for debilitated wellbeing and to survey the necessity for, and sufficiency of, nutritious intercession.

Track 8: Liver Injury and Immune Responses

Hepatic irritation is a typical finding amid an assortment of liver sicknesses including drug-prompted liver poisonous quality. The provocative phenotype can be credited to the intrinsic safe reaction produced by Kupffer cells, monocytes, neutrophils, and lymphocytes. The versatile invulnerable framework is additionally affected by the intrinsic resistant reaction prompting liver harm.

Track 9: Prevention and Treatment for Hepatitis

To diagnose hepatitis, first, your doctor will take your history to determine any risk factors you may have for infectious or noninfectious hepatitis. Liver function tests use blood samples to determine how efficiently your liver works.

High liver enzyme levels may indicate that your liver is stressed, damaged, or not functioning properly. An abdominal ultrasound uses ultrasound waves to create an image of the organs within your abdomen. It can reveal Liver tumours, Liver failure, Abnormalities of the gall bladder. Treatment options are determined by which type of hepatitis you have and whether the infection is acute or chronic.

Track 10: Hepatitis: Screening and Testing Methods

The disclosure of hepatitis infection (HV) has prompted the advancement of serological tests for the discovery of counteracting agent to this newfound infection. Gatherings at more serious danger of obtaining HV contamination incorporate intravenous medication clients, hemodialysis patients, haemophiliacs and blood transfusion beneficiaries. The screening of blood givers for hostile to HV has incredibly diminished the rate of post-transfusion hepatitis. One of the real issues with HV disease is the advancement of endless hepatitis in 50 to 60% of cases, which could prompt cirrhosis and hepatocellular carcinoma.

Track 11: Hepatitis, Liver Diseases and Pregnancy

Intense viral hepatitis is the most widely recognized reason for jaundice in pregnancy. The course of most popular contaminations isn't influenced by pregnancy. Jaundice is a trademark highlight of the liver malady. The clinical signs and side effects are unclear between the different types of viral hepatitis, subsequently, the differential determination requires serologic testing for an infection particular conclusion, and the finding is by a biochemical appraisal of liver capacity.

Track 12: Hepatitis and its Types

Hepatitis is an inflammation of the liver. The condition can be self-limiting or can progress to fibrosis (scarring), cirrhosis or liver cancer. Hepatitis viruses are the most common cause of hepatitis in the world but other infections, toxic substances (e.g. alcohol, certain drugs), and autoimmune diseases can also cause hepatitis.

There are 5 main hepatitis viruses, referred to as types Hepatitis A (HAV), Hepatitis B (HBV), Hepatitis C (HCV), Hepatitis D (HDV) and Hepatitis E (HEV). These 5 types are of greatest concern because of the burden of illness and death they cause and the potential for outbreaks and epidemic spread. In particular, types B and C lead to chronic disease in hundreds of millions of people and, together, are the most common cause of liver cirrhosis and cancer.

Track 13: Hepatitis B

Hepatitis B is a liver infection caused by the Hepatitis B virus (HBV). HBV is transmitted through activities that involve percutaneous or mucosal contact with infectious blood or body fluids. HBV can survive outside the body at least 7 days and still be capable of causing infection. The best way to prevent hepatitis B is by getting the hepatitis B vaccine. The pathogenesis and clinical manifestations of hepatitis B are due to the interaction of the virus and the host immune system, which lead to liver injury and potentially cirrhosis and hepatocellular carcinoma. Patients can have either an acute symptomatic disease or an asymptomatic disease.

Track 14: Hepatitis C

Hepatitis C is a devastating viral disease that generally progresses slowly, meaning patients often remain asymptomatic and unaware they are infected until very serious and often expensive complications emerge as a result of damage to the liver. It is estimated that about half of those infected are not aware that they carry the virus. The recent remarkable advances in treating hepatitis C built on incremental improvements achieved over the previous two decades to transform hepatitis C from a chronic, fatal disease, to an infection that with new and forthcoming treatments, can be potentially cured.

Track 15: Hepatitis Vaccination

The best way to prevent hepatitis is by getting the hepatitis vaccines. Vaccination is safe and effective and it is recommended for all. Efforts to develop a hepatitis C vaccine started more than 20 years ago, when the hepatitis C virus was identified. The hepatitis C virus is more variable than are the viruses that cause hepatitis A and hepatitis B. Hepatitis C virus occurs in at least six genetically distinct forms with 50 subtypes. A global vaccine would have to protect against all these variants of the virus.

Track 16: Hepatology and Nutrition

Gastroenterology, Hepatology and Nutrition the team of pediatric gastroenterologists, hepatologists, dietitians, clinicians and nurses are dedicated to helping children with common or complex gastrointestinal, liver and nutritional problems. The goals of the Gastroenterology Division are to provide outstanding medical care to persons with diseases of the gastrointestinal tract and liver, to train gastroenterology and to perform cutting-edge biomedical research to improve our understanding of digestive diseases.

Track 17: Hepatocellular Carcinoma and Trans arterial Chemo-Embolization

Hepatocellular carcinoma (HCC) is the most widely recognized kind of essential liver growth in grown-ups and is the most well-known reason for death in individuals with cirrhosis. It happens in the setting of incessant liver aggravation and is most firmly connected to endless viral hepatitis contamination (hepatitis B or C) or introduction to poisons, for example, liquor or Aflatoxin. Certain ailments, for example, hemochromatosis and alpha 1-antitrypsin lack, particularly increment the danger of treating HCC. Similarly, as with any malignancy, the treatment and forecast of HCC differ contingent upon the specifics of tumour histology, measure, how far growth has spread, and in general wellbeing.

Track 18: Liver Resection and Clinical Trails

Liver resection is the surgical removal of all or a portion of the liver. It is also referred to as a hepatectomy, full or partial. Complete liver resection is performed in the setting of a transplant a diseased liver is removed from a deceased donor (cadaver).  A living donor may also provide a piece of liver tissue which is procured through a partial hepatectomy. The procedure may be performed through a traditional open procedure or using minimally invasive techniques.

Market Analysis

Past Conference Report

Liver Congress 2018

We had successfully hosted the "3rd World Liver Congress" during December 17-18, 2018 Abu Dhabi, UAE. The conference was palmy in transfer along famous speakers from varied supposed organizations and their preponderant talks enlightened the gathering.

The pragmatic meet organized by our management received a generous response from the domain, gifted Keynote Speakers, Speakers, Young Researchers, Students & Business Delegates who attended from different parts of the world created their valuable contribution to form it as a successful event. The conference was marked with the presence of eminent Speakers, Young Researchers, Students & Business Delegates driving the event into the path of success with stimulating keynote shows.

 

The Conference focused on recent developments in the field of Liver Diseases and Hepatology. The meeting engrossed in knowledgeable discussions on novel subjects like:

Cellular and Molecular Gastroenterology & Hepatology

Liver Inflammation and Immunology

Liver Regeneration

Gene Expression in Liver

Hepato-Nephrology

Hepato-Cardiac and Pulmonary Disorders

Liver Cancer

Neurology and Liver Disease

Hepatic Pathology

Pediatric and Geriatric Hepatology

Hepato-Biliary Diseases

Hepatitis

Liver Disease and Pregnancy

Liver Transplantation and Surgery

Liver Imaging Modalities

Colorectal Disease: Treatments & Diagnosis

 

Special Session:

Title: Significant cohort of non-alcoholic fatty liver disease with

          portal vein thrombosis in the transplant waiting list (Turkey)+

          Metin Basaranoglu, Bezmialem Vakif University, Turkey

Title: Vomiting of surgical significance

          Amin Gohary, Burjeel Hospital, UAE

 

The proceedings of the conference were embarked with an opening ceremony followed by Special sessions and a series of Lectures delivered by both Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talks were:

Keynote forum:

Mohamed Miqdady, Sheikh Khalifa Medical City, UAE

Safwan A Taha, Mediclinic Airport Road Hospital, UAE

Amin Gohary, Burjeel Hospital, UAE

 

We extend our heartiest thanks to all the Organizing Committee Members for their kind support rendered towards the success of Tropical Diseases 2018. At an equivalent time, we take the chance to give thanks to all the speakers, delegates and participants for providing their valuable contribution and time for Tropical Diseases 2018.

 

Mohamed M. Abd El Ghaffar, Professor of pulmonary medicine, Menofia University, Egypt

Dimitris Roukos, Professor of Surgery, Ioannina University, Greece

Mohammed Ezz El Regal ABBAS, Faculty of medicine, Mansoura University, Egypt

 

Liver Congress 2018 Organizing Committee would really like to give thanks to the Moderator of the conference, who contributed plenty for the graceful functioning of this event.

With the encouragement from the wonderful feedback from the participants and supporters of Liver Congress 2018, Conference Series LLC Ltd is glad to announce "International Congress on Liver Diseases and Hepatology" on September 23-24, 2019 at Tokyo, Japan.

 

Let us meet again @ Liver Diseases 2019


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date December 02-03, 2019

For Sponsors & Exhibitors

sponsorship@conferenceseries.com

Speaker Opportunity

Supported By

Journal of Liver Journal of Hepatology and Gastrointestinal disorders Journal of Gastrointestinal & Digestive System Journal of Gastrointestinal Cancer and Stromal Tumors

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Past Affiliations

Speaker Logos

Keytopics

  • Acute Fatty Liver
  • Alcoholic Hepatitis
  • Alcoholic Steatohepatitis
  • Artificial Liver
  • Autoimmune Hepatitis
  • Fatty Liver Disease
  • Fibroscan
  • Fulminant Liver Failure
  • Gastroenterology
  • HCV/HIV Coinfection
  • Hemochromatosis
  • Hepatectomy
  • Hepatic Encephalopathy
  • Hepatic Failure
  • Hepatic Tumor
  • Hepatitis
  • Hepatitis Vaccination
  • Hepatocellular Carcinoma
  • Hepatology
  • Hepatomegaly
  • Hepatotoxicity
  • Herbal Liver Injury
  • Liver Abscess
  • Liver Cancer
  • Liver Cirrhosis
  • Liver Damage
  • Liver Diseases
  • Liver Imaging
  • Liver Infection
  • Liver Inflammation
  • Liver Injury
  • Liver Metastases
  • Liver Pathology
  • Liver Regeneration
  • Liver Resection
  • Liver Stiffness
  • Liver Tests
  • Liver Transplantation
  • Metastatic Liver Disease
  • New Therapies Of GI Cancer
  • Non Viral Hepatitis
  • Non-neoplastic Diseases
  • Nonalcoholic Steatohepatitis
  • Nonsteroidal Anti-inflammatory Drugs
  • Nutritional Issues
  • Obesity
  • Oesophageal Disease
  • Over The Counter (OTC) Drugs
  • Palliative Gastroenterology
  • Pancreas Divisum
  • Pancreatic Cancer
  • Pancreatic Cysts
  • Pancreatic Insufficiency
  • Pancreatico Biliary Systems
  • Pancreatitis
  • Peritoneal Infection
  • Peroral Endoscopic Myotomy
  • PH Probes
  • Primary Biliary Cirrhosis
  • Primary Sclerosing Cholangitis
  • Probiotics
  • Proton Pump Inhibitors
  • Proton-pump Inhibitors
  • Push Enteroscopy
  • Radiology
  • Rectoscopy
  • Robotic Surgery
  • Short Bowel Syndrome
  • Stomach Cancer
  • Stool Tests
  • Transplant Surgery
  • Ulcer
  • Ulcerative Colitis
  • Upper Gastrointestinal Endoscopy
  • Viral Hepatitis
  • Whipple's Disease
  • Wilson's Disease